Cumulus Neuroscience appoints SiggiSaevarsson as COO

February 10, 2023

Cumulus Neuroscience announces that Siggi Saevarsson has been appointed asChief Operating Officer (COO).

Saevarsson is an entrepreneur with more than 20 years of experience in venture capital and fast-growing technology companies. His areas of expertise include product- and operations management as well as corporate strategy, and M&A.

He has occupied senior management roles and been on the board of directors forseveral high-growth start-ups, as well as working directly for Intel Corporation, Nokia, OpenWave and other telecoms technology companies. He has a degree in Computer Science and Business Administration from Copenhagen Business Schooland Carnegie Mellon University.

Cumulus Neuroscience’s CEO Ronan Cunningham commented: “We are delightedto bring Siggi on board at such an important time for Cumulus. We have a busy year ahead as we greatly expand the clinical activity for our integrated physiological and digital CNS biomarker platform. Siggi brings deep experience in scaling and growing high-technology companies and will play a pivotal role in ensuring that Cumulus realizes its full potential”

Siggi Saevarsson, newly appointed COO, added: “Cumulus has made fantastic progress and I am excited to be joining the company for the next stage of its evolution. Dementia and other neurodegenerative diseases remain an area of huge unmet need in healthcare. Cumulus’ multi-modal, cloud-based technology platform has the potential to revolutionise data acquisition in neuroscience and play an important role in the development and delivery of new therapies.”